ANTIMICROBIAL ACTIVITY OF METHANOL EXTRACT AND FRACTIONS OF MORINGA OLEIFERA LAM. ROOT BARK ON CLINICAL ISOLATES OF METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS

 

Table Of Contents


  • <p> </p><p>Title page &nbsp; — &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – i &nbsp; &nbsp; </p><p>Declaration — &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; -ii</p><p>Approval page — &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; -iii</p><p>Dedication — &nbsp; &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; -iv</p><p>Acknowledgement — &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; -v &nbsp; &nbsp; </p><p>Table of content &nbsp; — &nbsp; &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; -vi &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Abstract — &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; – &nbsp; &nbsp; &nbsp; -vii</p> <br><p></p>

Project Abstract

<p> </p><p><br>Development of <a target="_blank" rel="nofollow" href="https//www.modishproject.com/antimicrobial-activity-crude-methanol-extract/">antimicrobial</a>&nbsp;resistance by bacteria is now a world wide health issue, as infection is one of the leading causes of death in the world today. This fact is also as a result of the emergence of multiple antibiotic resistant bacteria known as methicillin resistant Staphylococcus aureus (MRSA) with potential of cross resistance to other antibiotics of</p><p>choice like vancomycin. MRSA is often referred to as a <a target="_blank" rel="nofollow" href="https//www.modishproject.com/the-effect-of-exchange-rate-on-the-nigerian-balance-of-payments-1970-2010/">potential killer</a>&nbsp;and one of the tree top superbugs in hospitals multidrug resistant organisms (MDRO). The aim of this study was to evaluate the phytochemical components and antimicrobial activity of methanol extract and fractions of Moringa oleifera root bark as possible remedy for MRSA infections.</p><p><a target="_blank" rel="nofollow" href="https//www.modishproject.com/invitro-determination-of-bacteriocidal-effect-of-garlic-on-staphylococcus-aureus/">Staphylococcus</a>&nbsp;aureus isolates from 3 different hospitals in South-east geopolitical region of Nigeria were confirmed by coagulase/staphylase test using Oxoid® reagents kits (DR0595A). The characterised S. aureus isolates were further identified as Methicillin resistant staphylococcus aureus by disc diffusion method as recommended by the Clinical Laboratory Standards Institute (CLSI), using standard antibiotic discs containing oxacillin (5 μg/ml), vancomycin (30 μg/ml), cephalexin (30 μg/ml), levofloxacin (5 μg/ml), ciprofloxacin (5 μg/ml), tetracycline (30 μg/ml), cotrimoxazole (25 μg/ml), gentamicin (30 μg/ml), clindamycin (2 μg/ml) and rifampicin (5 μg/ml). Methicillin resistant staphylococcus aureus</p><p>confirmation was done using Oxoid® DR0900 penicillin binding protein (pbp2ˈ) latex agglutination test kits. Pulverised Moringa oleifera root bark was defatted with n-hexane to yield hexane fraction (HEF). The dried marc was extracted with methanol using Soxhlet extractor to obtain crude methanol extract (ME). Methanol extract was adsorbed on Silical gel (60-200 mesh) and eluted in succession to obtain dichloromethane fraction (DMF), ethyl acetate fraction (EAF) and methanol fraction (MEF). Qualitative phytochemical analyses of the extracts were carried out using standard procedures. The antimicrobial activities of ME, HEF, DMF, EAF and MEF were evaluated on the MRSA, the minimum inhibitory concentrations (MICs) and <a target="_blank" rel="nofollow" href="https//www.modishproject.com/antibacterial-phytochemical-properties-phyllanthus/">minimum bactericidal concentrations</a>&nbsp;(MBCs) were recorded and compared with the standard disc antimicrobial test results. The extract fractions were analysed using gas chromatographic-mass spectrometry (GC-MS) for their bioactive compounds. The preliminary acute toxicity and sub-acute toxicity of ME and HEF were evaluated. Statistical analysis was done with ANOVA followed by Duncan post Hoc test using SPSS v 17 software. Characterised clinical isolates yielded 58 S. aureus strains. Antibiotic susceptibility tests indicated varied percentages of MRSA that were resistant to various antibiotics thus oxacillin (62.1 ± 3.2%), vancomycin (60.4 ± 3.8%), cephalexin (55.2 ± 1.2%), levofloxacin (56.9 ±</p><p>2.2%), ciprofloxacin (56.9 ± 0.9%), tetracycline (65.5 ± 2.3%), cotrimoxazole (68.9 ± 0.8%), gentamicin (67.2 ± 1.3%), clindamycin (62.1 ± 3.3%) and rifampicin (62.1 ± 4.1%). Latex agglutination test confirmed 39 strains of the clinical isolates to be MRSA. The S. aureus isolates resistant to all the antibiotics including vancomycin at 30 μg/ml were sensitive to the</p><p>extract and all its fractions ME MIC (3.0 ± 0.1 to 5.0 ± 0.5 mg/ml) and MBC (3.0 ± 0.1 to 6.0 ± 0.5 mg/ml); EAF MIC (5.0 ± 1.1 to 8.0 ± 0.5 mg/ml) and MBC (5.0 ± 0.5 to 8.0 ± 0.5 mg/ml); DMF MIC (8.0 ± 1.1 to 10 ± 0.5 mg/ml) and MBC (8.0 ± 0.5 to 10 ± 0.5 mg/ml); HEF MIC (7.0 ± 0.5 to 8 ± 1.1 mg/ml) and MBC (7.0 ± 0.5 to 9 ± 0.5 mg/ml), MEF MIC (9.0 ± 1.1 to 10.0 ± 0.5 mg/ml) and MBC (9.0 ± 0.5 to 10.0 ± 0.5 mg/ml).</p><p>Phytochemical analysis of the extracts showed the presence of <a target="_blank" rel="nofollow" href="https//www.modishproject.com/presence-concentration-avocado/">alkaloids, glycosides, steroids, terpenoids, flavonoids, saponins</a>, tannins, resins, reducing sugars, proteins, fats and oil and carbohydrates. GC-MS analysis revealed over 100 distinct compounds, some of which are stigmasterol (C29H48O), eugenol (C10H12O2), oxime (C3H7NO ) and ergosta-4, 22-dien-3-one (C28H44O). The oral acute toxicity test showed the LD50 of ME as 3663.96 mg/kg and HEF as 1934.15mg/kg, with no significant change (P &gt; 0.05) in the hematological, serum biochemical parameters and weight of the rats</p> <br><p></p>

Project Overview

Blazingprojects Mobile App

📚 Over 50,000 Project Materials
📱 100% Offline: No internet needed
📝 Over 98 Departments
🔍 Software coding and Machine construction
🎓 Postgraduate/Undergraduate Research works
📥 Instant Whatsapp/Email Delivery

Blazingprojects App

Related Research

Pharmacy. 2 min read

Development of a Nanoparticle-based targeted drug delivery system for cancer therapy...

What This Project Is About This project explores how tiny particles called nanoparticles can be used to deliver medicines directly to cancer cells. The goal is ...

BP
Blazingprojects
Read more →
Pharmacy. 3 min read

Development of a Nano-Formulated Drug Delivery System for Enhanced Bioavailability o...

What This Project Is About This project focuses on creating tiny particles, called nanoparticles, that can carry cancer-fighting drugs. These tiny carriers are ...

BP
Blazingprojects
Read more →
Pharmacy. 3 min read

Development of a Novel Nano-Formulation for Enhanced Delivery of Poorly Soluble Anti...

What This Project Is About This project focuses on developing tiny particles called nano-formulations that can carry anticancer drugs which do not dissolve well...

BP
Blazingprojects
Read more →
Pharmacy. 3 min read

Development and Evaluation of a Nanoformulated Drug Delivery System for Enhanced Bio...

This project is about creating a special delivery system that uses tiny particles, called nanoparticles, to help deliver an anticancer drug more effectively in ...

BP
Blazingprojects
Read more →
Pharmacy. 4 min read

Development of a Novel Nano-Formulation for Enhanced Delivery of Anticancer Agents...

This project is about creating a new type of tiny particles, called nano-formulations, to carry and deliver cancer-fighting medicines more effectively inside th...

BP
Blazingprojects
Read more →
Pharmacy. 3 min read

Development of Nano-Formulated Targeted Drug Delivery Systems for Cancer Therapy...

This project is about creating tiny particles, called nano-formulated systems, that can deliver medicine directly to cancer cells in the body. The main goal is ...

BP
Blazingprojects
Read more →
Pharmacy. 3 min read

Development and Evaluation of Novel Drug Delivery Systems for Targeted Cancer Therap...

The project titled &quot;Development and Evaluation of Novel Drug Delivery Systems for Targeted Cancer Therapy&quot; aims to address the critical need for more ...

BP
Blazingprojects
Read more →
Pharmacy. 3 min read

Development and Evaluation of Novel Drug Delivery Systems for Improved Patient Compl...

The project titled &quot;Development and Evaluation of Novel Drug Delivery Systems for Improved Patient Compliance&quot; aims to address the critical issue of p...

BP
Blazingprojects
Read more →
Pharmacy. 4 min read

Development of novel drug delivery systems for targeted cancer therapy...

The project titled &quot;Development of novel drug delivery systems for targeted cancer therapy&quot; aims to address the pressing need for more effective and l...

BP
Blazingprojects
Read more →
WhatsApp Click here to chat with us